EMcision Limited

EMcision Limited in its sale to Boston Scientific Corporation

Client

EMcision Limited

Value

-

Service

Mergers and Acquisitions

Date Closed

March 2018

Industry

Health

Lead Office

Montréal


On March 5, 2018, Boston Scientific Corporation, one of the world’s premier medical devices companies, acquired EMcision Limited, a privately-held, top-tier medical device company based in the UK and operating throughout the US.  

The acquisition will significantly expand Boston Scientific’s device portfolio; EMcision devices are sold in 38 countries around the world and used in most of the top US cancer centres.

Osler, Hoskin & Harcourt LLP represented EMcision with a team consisting of Shahir Guindi, Raphaël Amram and and Mark Brender (Tax).


Team
Mark Brender - International Tax Lawyer

Mark Brender

Partner, Taxation